Journal articlePancreatology2019

FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer.

DOI 10.1016/j.pan.2019.01.014 ↗ OpenAlex, retrieved 5 November 2026

Journal: Pancreatology
Published: 19 January 2019
Citations: 4
Type: Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try